🇺🇸 Mucolytic in United States

19 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Dyspnoea — 3 reports (15.79%)
  2. Respiratory Failure — 3 reports (15.79%)
  3. Bile Duct Obstruction — 2 reports (10.53%)
  4. Hypoxia — 2 reports (10.53%)
  5. Multi-Organ Failure — 2 reports (10.53%)
  6. Productive Cough — 2 reports (10.53%)
  7. Pyrexia — 2 reports (10.53%)
  8. Abdominal Distension — 1 report (5.26%)
  9. Abdominal Pain — 1 report (5.26%)
  10. Alanine Aminotransferase Increased — 1 report (5.26%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Mucolytic approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Mucolytic in United States?

Shanghai Pulmonary Hospital, Shanghai, China is the originator. The local marketing authorisation holder may differ — check the official source linked above.